Intrapartum magnesium sulfate and the potential for cardiopulmonary drug-drug interactions.

Campbell, Sarah C; Stockmann, Chris; Balch, Alfred; Clark, Erin A S; Kamyar, Manijeh; Varner, Michael; Korgenski, E Kent; Bonkowsky, Joshua L; Spigarelli, Michael G; Sherwin, Catherine M T

Campbell, Sarah C; Stockmann, Chris; Balch, Alfred; Clark, Erin A S; Kamyar, Manijeh; Varner, Michael; Korgenski, E Kent; Bonkowsky, Joshua L; Spigarelli, Michael G; Sherwin, Catherine M T.

Afiliação

Campbell SC; *Division of Clinical Pharmacology, Department of Pediatrics, University of Utah; Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah School of Medicine; Intermountain Healthcare, Women and Newborns Clinical Program; §Intermountain Healthcare, Pediatric Clinical Program; and ¶Division of Pediatric Neurology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah.

Ther Drug Monit ; 36(4): 544-8, 2014 Aug.

Article em En | MEDLINE | ID: mdl-24487252

Assuntos

Interações Medicamentosas/fisiologia; Sulfato de Magnésio/efeitos adversos; Adulto; Feminino; Humanos; Preparações Farmacêuticas/administração & dosagem; Gravidez; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interações Medicamentosas / Sulfato de Magnésio Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google